The company identified 7 studies from the clinical evidence search which incorporated an economic analysis. However, it was unable to draw any firm conclusions from these studies. The external ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Kaneka, a global leader ...
The rollout marks a major step in reducing childhood deaths from sickle cell disease through early screening and advanced ...
In a significant step toward expanding treatment access for people with rare and chronic diseases in Latin America (LATAM), Terumo Blood and Cell Technologies (Terumo BCT), announced that its Spectra ...
AllAfrica on MSN
Victoria Hospital in Kisumu Becomes First Public Facility in Kenya to Offer Advanced Sickle Cell Treatment
KISUMU, Kenya, Jan 26 -- Victoria Hospital in Kisumu, an annex of the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), has become the first public hospital in Kenya to acquire a ...
The Spectra Optia Apheresis System (Terumo BCT) is an apheresis and cell collection platform which can be used in the treatment of sickle cell disease. The purpose of this evaluation is to assess the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results